Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells [Amp-seq]

ABSTRACT: HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells [Amp-seq]

PROVIDER: PRJNA935730 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23498104_1.fastq.gz	Fastqsanger.gz
	SRR23498104_2.fastq.gz	Fastqsanger.gz
	SRR23498105_1.fastq.gz	Fastqsanger.gz
	SRR23498105_2.fastq.gz	Fastqsanger.gz
	SRR23498106_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells [Amp-seq]

Project description:We have established a technology to endorse DSB resolution via HDR with the goal of facilitating clinical transition of HDR-based editing strategies and increase safety. We have used high throughput sequencing as deposited here to assess safety of our platform

2023-08-11 | GSE225450 | GEO

HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells

Project description:HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells

| PRJNA935715 | ENA

HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells [CAST-seq]

2023-08-11 | GSE225449 | GEO

HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells [CAST-seq]

Project description:HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells [CAST-seq]

| PRJNA935729 | ENA

HDR-CRISPR promotes targeted genome editing with reduced mutational burden in primary human cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-08-11 | GSE225452 | GEO

Characterization of tumor mutational burden in LKB1 mutant lung tumors

Project description:Characterization of tumor mutational burden in LKB1 mutant lung tumors

| PRJNA564852 | ENA

Characterization of tumor mutational burden in LKB1 mutant lung tumors

Project description:Inactivating mutations in LKB1/STK11 are present in ~20% of non-small cell lung cancers (NSCLC) and portend poor response to anti-PD-1 immunotherapy in patients and genetically engineered mouse model (GEMMs). Here, we sought to uncover the basis for immunotherapy resistance of these tumors and to define strategies that overcome this barrier. Whereas high tumor mutational burden (TMB) often correlates with response to anti-PD1 treatment, we found that LKB1-deficient NSCLCs from non-smokers and GEMMs exhibited striking elevations in nonsynonymous mutations compared to LKB1 wildtype tumors. Correspondingly, LKB1 mutant NSCLC cell lines showed defects in both replication dependent and independent double-strand DNA break (DSB) repair, which were reversed upon LKB1 re-expression.

2021-03-17 | GSE137244 | GEO

Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal Myxoid Chondrosarcoma

Project description:Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal Myxoid Chondrosarcoma

| PRJNA974549 | ENA

Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal Myxoid Chondrosarcoma

Project description:Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal Myxoid Chondrosarcoma

| PRJNA974550 | ENA

Panicum virgatum strain:HDR | cultivar:HDR

Project description:Panicum virgatum HDR Resequencing genome sequencing

| PRJNA334737 | ENA